Main content
EXPO Trial
Date created: | Last Updated:
: DOI | ARK
Creating DOI. Please wait...
Category: Project
Description: Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): An Open Label Randomised Controlled Trial of Injectable Depot Maintenance Buprenorphine versus Standard-Of-Care Oral Maintenance Opioid Agonist/Partial Opioid Agonist Medication, with Personalised Psychosocial Intervention. The EXPO study.